GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » COGS-to-Revenue

Molekule Group (FRA:9O6) COGS-to-Revenue : 0.66 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group COGS-to-Revenue?

Molekule Group's Cost of Goods Sold for the three months ended in Jun. 2023 was €8.09 Mil. Its Revenue for the three months ended in Jun. 2023 was €12.22 Mil.

Molekule Group's COGS to Revenue for the three months ended in Jun. 2023 was 0.66.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Molekule Group's Gross Margin % for the three months ended in Jun. 2023 was 33.82%.


Molekule Group COGS-to-Revenue Historical Data

The historical data trend for Molekule Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group COGS-to-Revenue Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
COGS-to-Revenue
- - 0.55 0.49

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.53 0.47 0.56 0.66

Molekule Group COGS-to-Revenue Calculation

Molekule Group's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.105 / 0.214
=0.49

Molekule Group's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=8.089 / 12.223
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group  (FRA:9O6) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Molekule Group's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 8.089 / 12.223
=33.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Molekule Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Molekule Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (FRA:9O6) Business Description

Traded in Other Exchanges
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines